biolitec AG

Head and Neck Cancer Patients, Who do Not Respond to Other Treatment, highly Benefit from Photodynamic Therapy with Medicament Foscan® of biolitec AG

Patients with head and neck cancer, who are otherwise unresponsive to further treatment, can derive great benefit from treatment with photodynamic therapy (PDT) and Foscan®. This has been confirmed by researchers in a European author team led by the Nederlands Kanker Instituut - Antoni van... - May 01, 2010